Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07OKT
|
|||
| Former ID |
DNC005039
|
|||
| Drug Name |
3-Carbazol-9-yl-propionic acid
|
|||
| Synonyms |
6622-54-4; 3-(9H-carbazol-9-yl)propanoic acid; 3-carbazol-9-ylpropanoic acid; CHEMBL184817; Carbazole-9-propionic acid; NSC400; Carbazol-N-propionsaure; AC1Q75LO; AC1Q5WE7; TimTec1_004366; Oprea1_037143; Oprea1_183633; SCHEMBL150033; 9H-Carbazole-9-propionic acid; AC1L56H9; DTXSID30277021; 3-(carbazol-9-yl)propanoic acid; NSC-400; MolPort-000-474-043; 3-(Carbazol-9-yl)propionic acid; HMS1546G10; NSC54636; ZINC1841595; STK387004; BDBM50152856; 7615AE; BBL007862; SBB010078
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H13NO2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C3=CC=CC=C3N2CCC(=O)O
|
|||
| InChI |
1S/C15H13NO2/c17-15(18)9-10-16-13-7-3-1-5-11(13)12-6-2-4-8-14(12)16/h1-8H,9-10H2,(H,17,18)
|
|||
| InChIKey |
ZAJJJOMMWPVJMH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 6622-54-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
| KEGG Pathway | PPAR signaling pathway | |||
| NetPath Pathway | TCR Signaling Pathway | |||
| Pathway Interaction Database | AP-1 transcription factor network | |||
| Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
| Transcriptional regulation of white adipocyte differentiation | ||||
| WikiPathways | Lipid digestion, mobilization, and transport | |||
| Transcriptional Regulation of White Adipocyte Differentiation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.